Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-216.52	-231.07	-73.00
Graham Fair Price	-87.03	7206.27	55545.22
PEG	55339.61	-3.30	< 0.005
Price/Book	-26.62	1.27	1.73
Price/Cash Flow	-8.51	10.14	-11.08
Prices/Earnings	4278.51	336.75	-7.69
Price/Sales	-19.19	2.50	3.10
Price/FCF	-8.51	10.14	-11.08
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.22	0.02	-0.03
Operating Margin	82.59	-0.01	-0.06
ROA	-98.26	< 0.005	-0.02
ROE	-0.06	< 0.005	-98.32
ROIC	-0.02	< 0.005	88.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.23	0.55	-58.22
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-7.84	0.84	-89.26
EPS QOQ	-12.90	1.02	-92.10
FCF QOQ	-9.72	1.80	-81.44
Revenue QOQ	0.11	-0.09	-15.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	18.30	24.37	33.19
Days Sales Outstanding (DSO)	131.77	118.36	-10.18
Inventory Turnover	4.92	3.69	-24.92
Debt/Capitalization	0.23	0.18	-19.48
Quick Ratio	0.72	0.71	-0.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	49395.88	49504.32	0.22
Cash	8753.36	11330.57	29.44
Capex	-866.45	-651.59	24.80
Free Cash Flow	-7705.48	6193.68	-19.62
Revenue	27568.12	25085.25	-9.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.02	1.05	2.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.59	-3.36	39.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating